Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Zafar Hussain is active.

Publication


Featured researches published by Zafar Hussain.


Diagnostic Microbiology and Infectious Disease | 2011

Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007-2009 study.

Kimberly A. Nichol; Heather J. Adam; Zafar Hussain; Michael R. Mulvey; Melissa McCracken; Laura Mataseje; Kristjan Thompson; Sara Kost; Philippe Lagacé-Wiens; Daryl J. Hoban; George G. Zhanel

This study assessed the demographics, antimicrobial susceptibility, and molecular epidemiology of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) and health care-associated MRSA (HA-MRSA) in Canadian hospitals between 2007 and 2009. Among 3589 S. aureus, 889 (24.8%) were MRSA; 224 (25.2%) were CA-MRSA genotypes and 644 (72.4%) were HA-MRSA genotypes. The prevalence of CA-MRSA genotypes increased from 19.5% in 2007 to 31.9% in 2009 (P < .001). CMRSA10/USA300 (73.7%) was the predominant CA-MRSA epidemic type; the most common HA-MRSA epidemic type was CMRSA2/USA100/800 (83.5%). CA-MRSA genotypes carried SCCmec type IVa (98.2%) and were largely agr type I (73.2%). Most HA-MRSA genotypes were SCCmec type II (81.2%) and agr type II (83.4%). Panton-Valentine leukocidin was detected in 201/224 (89.7%) CA-MRSA genotypes and 3/644 (0.5%) HA-MRSA genotypes. An increase in vancomycin minimum inhibitory concentration (MIC) was observed in HA-MRSA genotypes overall, with 1.3% (4/305) of strains in 2007 and 4.6% (7/152) in 2009 exhibiting vancomycin MICs of 2 μg/mL. No MRSA resistance occurred with linezolid, daptomycin, or tigecycline. In conclusion, CA-MRSA genotypes represented 25.2% of all MRSA and continue to increase in prevalence in Canadian hospitals.


Diagnostic Microbiology and Infectious Disease | 1987

Comparison of susceptibility results of anaerobic organisms determined by agar dilution method and Sceptor Anaerobe MIC/ID Micro Broth Dilution Panels.

Zafar Hussain; Robert Lannigan; B.C. Schieven; Luba Stoakes; D. Groves

A commercial broth microdilution system (Sceptor Anaerobe MIC/ID, BBL) for susceptibility testing of anaerobic bacteria was compared to a reference agar dilution system. Of the 172 organisms tested, only 7% failed to grow sufficiently for testing in the Sceptor system. In 1,590 antibiotic/organism combinations, 86.7% of the Sceptor results were identical or within one doubling dilution of the reference system. In 91.9% of the cases, interpretation of the results was same in both systems. Two hundred and twelve MIC values, however, differ by greater than or equal to 2 log2 dilution from the reference system. Due to this reduced correlation in the actual MIC values with the reference results, further studies are warranted before the Sceptor system can be recommended for routine use.


Journal of Clinical Microbiology | 2000

Correlation of oxacillin MIC with mecA gene carriage in coagulase-negative staphylococci.

Zafar Hussain; Luba Stoakes; Viki Massey; Deb Diagre; Viivi Fitzgerald; Sameer El Sayed; Robert Lannigan


Journal of Clinical Microbiology | 2000

Rapid detection of mecA-positive and mecA-negative coagulase-negative staphylococci by an anti-penicillin binding protein 2a slide latex agglutination test.

Zafar Hussain; Luba Stoakes; Shaunalee Garrow; Susan Longo; Viivi Fitzgerald; Robert Lannigan


Journal of Clinical Microbiology | 1994

Gas-liquid chromatography of cellular fatty acids for identification of staphylococci.

Luba Stoakes; Michael John; Robert Lannigan; B C Schieven; M Ramos; D Harley; Zafar Hussain


Diagnostic Microbiology and Infectious Disease | 2007

Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples.

Romina C. Reyes; Michael John; Diane L. Ayotte; Alexia Covacich; Susan Milburn; Zafar Hussain


Journal of Clinical Microbiology | 1991

Gas-liquid chromatographic analysis of cellular fatty acids for identification of gram-negative anaerobic bacilli.

Luba Stoakes; T Kelly; B C Schieven; D Harley; M Ramos; Robert Lannigan; D Groves; Zafar Hussain


Journal of Clinical Microbiology | 1992

Evaluation of MicroScan Rapid Pos Combo panels for identification of staphylococci.

Luba Stoakes; B C Schieven; E Ofori; P Ewan; Robert Lannigan; Zafar Hussain


Journal of Clinical Microbiology | 1990

Accuracy and reproducibility of the MicroScan rapid anaerobe identification system with an automated reader.

Luba Stoakes; T Kelly; K Manarin; B C Schieven; Robert Lannigan; D Groves; Zafar Hussain


The Canadian Journal of Hospital Pharmacy | 2002

Antibiotic Use in a Family Practice Setting

Susan Karakashian; Zafar Hussain; James A. McSherry; Amanda J. Adams; Barbara Lent; Stephen J. Wetmore; Anne Marie Bombassaro

Collaboration


Dive into the Zafar Hussain's collaboration.

Top Co-Authors

Avatar

Luba Stoakes

London Health Sciences Centre

View shared research outputs
Top Co-Authors

Avatar

Robert Lannigan

London Health Sciences Centre

View shared research outputs
Top Co-Authors

Avatar

Anne Marie Bombassaro

London Health Sciences Centre

View shared research outputs
Top Co-Authors

Avatar

Michael John

University of Western Ontario

View shared research outputs
Top Co-Authors

Avatar

Viivi Fitzgerald

London Health Sciences Centre

View shared research outputs
Top Co-Authors

Avatar

Alexia Covacich

London Health Sciences Centre

View shared research outputs
Top Co-Authors

Avatar

Amanda J. Adams

London Health Sciences Centre

View shared research outputs
Top Co-Authors

Avatar

Barbara Lent

London Health Sciences Centre

View shared research outputs
Top Co-Authors

Avatar

Cheryl Thompson

London Health Sciences Centre

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge